News

Acadia Pharmaceuticals, the maker of Nuplazid (pimavanserin), an oral medication to treat hallucinations and delusions associated with Parkinson’s disease (PD), was ranked 11th on Forbes Magazine’s 2017 list of the “World’s Most Innovative Growth Companies.” Forbes’ ranking is based on the ‘innovation premium’ of each…

Researchers are one step closer to fully understanding how a group of proteins, called the AMPA receptors, work — potentially gaining an insight into how neurological diseases like Parkinson’s develop in the brain, a new study reports. These findings may also help in the design of new treatment approaches. The study, titled…

In this video from Parkinson’s UK, people living with Parkinson’s disease talk about the effect the condition has had on their lives and offer some tips for anyone who has been recently diagnosed. MORE: Seven hand exercises for people with Parkinson’s disease Some of…

Hong Kong has issued a patent to Intec Pharma for its investigational Accordion Pill Carbidopa/Levodopa (AP-CD/LD) drug delivery for Parkinson’s disease symptoms in advanced patients. The patent (HK1158545) is titled “Carbidopa/Levodopa Gastroretentive Drug Delivery” and is scheduled to remain active until April 2029. The patent belongs to Intec’s IN-7 patent family that…

Prana Biotechnology and Takeda Pharmaceuticals International are teaming up to investigate whether Prana’s PBT434 can improve gastrointestinal damage associated with Parkinson’s disease. PBT434 showed promise as a treatment for neuronal loss and movement problems in mice with Parkinson’s, according to a preclinical-trial study. The collaboration will deal with…

When a resupply mission lifts off in August bound for the International Space Station, it will be carrying an important cargo for researchers studying Parkinson’s disease: a protein considered  to be a key to potential future therapies. The leucine-rich repeat kinase 2 (LRRK2) protein will be the focus of an experiment conducted…

The Parkinson’s Disease Digital Biomarker DREAM Challenge was just launched by Sage Bionetworks as the first of a series of open, crowd-funded projects designed to help researchers identify ways to use smartphones and remote sensing devices to monitor health and disease. The first DREAM Challenge will focus on…

A Centers for Disease Control and Prevention (CDC) study of more than 12 million people who died in the U.S. between 1985 and 2011 found that deaths from Parkinson’s disease and ALS (amyotrophic lateral sclerosis) occurred more often in people in higher socioeconomic status (SES) occupations. Findings from the study…

Tuppy Owens, a sex therapist who works and advocates on behalf of the disabled, will hold an online lecture on  July 26 focusing on sexuality in the context of chronic conditions, including Parkinson’s disease, and how patients and caregivers can best enjoy this aspect of their lives. Registration is free for…

University of Houston researchers are developing what’s called the Smarter Balance System (SBS), a smartphone-based biofeedback rehabilitation system to help patients with Parkinson’s disease regain stable balance. This helps them with confidence in performing daily activities through a series of exercises using a piece of wearable technology.